On the other hand, a relatively recent study found higher serum levels of Ang-1 in NSCLC patients compared to the control cohort, while no further association between the concentration of Ang-1 and the treatment’s outcome was identified [45]. This evidence concerns the gene ANGPT1 and non-small cell lung carcinoma.